|
Results of a quality improvement program to increase complete lung cancer biomarker testing rates by focusing on system, physician, and other factors associated with adverse health outcomes
Journal of Clinical Oncology 42, 2024 (suppl 16; abstr e23249) doi.org/10.1200/JCO.2024.42.16_suppl.e23249 Evaluating perceived barriers to optimal care in head and neck cancer: A mixed-methods study Journal of Clinical Oncology 42, 2024 (suppl 16; abstr 6079) ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.6079 Integrating electronic health records (EHRs) to facilitate cancer biomarker testing: Real-world implementation barriers and solutions Journal of Clinical Oncology 42, 2024 (suppl 16; abstr e13649) doi.org/10.1200/JCO.2024.42.16_suppl.e13649 Comments are closed.
|
Author@DrJosephKim Sign up to receive updates:
|
